Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Ribi, ATL collaborate on the development of improved allergy vaccines

Oct. 20, 1998

Certiva vaccine launched in the U.S.

Oct. 16, 1998

Orphan drug designation granted to MEDI-507 for use in AlloMune system

Oct. 16, 1998

Data safety monitoring board deems Nabi S. aureus vaccine safe in hemodialysis patients

Oct. 16, 1998

Aquila reports preliminary results of phase II trial of pneumococcal vaccine

Oct. 16, 1998

New compound reported in clinical development at Lilly

Oct. 15, 1998

Immunomodulating thalidomide analogues patented by Gruenenthal

Oct. 14, 1998

Ono's new PGE2 derivatives show binding affinity for EP2 receptors

Oct. 13, 1998

Development status updated for 3M's imiquimod analogue R-848

Oct. 7, 1998

La Jolla enrolls patients in phase II/III trial for lupus treatment

Oct. 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...